• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB AMVISC VISCOSURGICAL DEVICE; AID, SURGICAL, VISCOELASTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB AMVISC VISCOSURGICAL DEVICE; AID, SURGICAL, VISCOELASTIC Back to Search Results
Model Number 59081L
Device Problems Detachment of Device or Device Component (2907); Device Handling Problem (3265)
Patient Problems Hemorrhage/Bleeding (1888); Vitreous Loss (2142); Vitreous Hemorrhage (2143); Capsular Bag Tear (2639)
Event Date 08/06/2018
Event Type  Injury  
Manufacturer Narrative
Investigation of this event is in progress.A follow-up report will be submitted upon completion of the investigation.
 
Event Description
It was reported that while the surgeon was injecting viscoelastic into the patient¿s eye, the cannula came off and penetrated the posterior chamber.Reportedly, the scrub nurse pulled the rubber stopper from the end of the syringe (instead of twisting as described in the dfu) and inadvertently pulled the luer-lock off.Cannula was attached and the syringe was then passed to the surgeon, who tightened the cannula and held the hub during injection of the amvisc viscoelastics, but did not realize the luer-lock was not on the syringe.Some amvisc viscoelastics was expelled outside the eye to repress bubbles/air, but the cannula did not detach.The cannula; however, detached under pressure during injection into the anterior chamber.Initially, no significant ocular injury was noticed.Continuous curvilinear capsulorhexis was completed, but rotation of the implanted lens was not possible in the bag after first groove, even after repeated hydrodissection was performed.The lens was grooved and cracked without rotation and partially removed and elevated with amvisc viscoelastics.After removal of most of the lens, it was clear there was a large posterior capsule rent and vitreous fluid in the anterior chamber.As a precaution, pars plana vitrectomy (ppv) ports were placed and when infusion turned on, it was evident that vitreous hemorrhage was present and began to circulate in the anterior chamber and vitreous.At this point, possible retinal injury was suspected.The lens and vitreous fluid were removed from the anterior segment and binocular indirect ophthalmic microscope (biom) was placed with intention to inspect retina and treat any retinal break, but no fundal view was possible.The patient was in significant pain and the procedure was abandoned.Additional information has been requested, but has not be been received.
 
Manufacturer Narrative
Based upon the complaint trend review, the volume of complaints is within the acceptable control limits and no complaint trend is observed.The product is being enhanced with a retention clip to mitigate the possibility of user error as occurred in this event.
 
Manufacturer Narrative
Additional information: the lens was not available for evaluation; therefore, a product evaluation could not be performed.The device history record (dhr) was reviewed and there were no discrepancies or deviations found that related to the reported issue.Based on the available information, the event is likely attributed to failure in following the directions for use (dfu) for the device.
 
Event Description
Reportedly, the surgery was terminated as the patient had an intraoperative choroidal hemorrhage, which according to the surgeon, the best management for treating was to increase the intraocular pressure that would potentially limit the bleeding.The surgeon therefore terminated the surgery so the eye would be a closed system.The patient had several follow-up visits since surgery and has had laser treatment (cyclodiode) to control elevated intraocular pressure.A b-scan ultrasound has confirmed the presence of choroidal hemorrhage.No further intervention is planned at the moment.The patient has guarded prognosis for achieving good vision.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMVISC VISCOSURGICAL DEVICE
Type of Device
AID, SURGICAL, VISCOELASTIC
Manufacturer (Section D)
BAUSCH + LOMB
1400 north goodman street
rochester NY 14609
MDR Report Key7853779
MDR Text Key119488151
Report Number0001313525-2018-00160
Device Sequence Number1
Product Code LZP
Combination Product (y/n)Y
PMA/PMN Number
P810025
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 08/06/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/06/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2019
Device Model Number59081L
Device Catalogue Number59081L
Device Lot Number026946
Was Device Available for Evaluation? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age87 YR
-
-